• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接枝有普朗尼克的聚酰胺-胺树枝状大分子缀合物克服乳腺癌的耐药性。

Pluronic-attached polyamidoamine dendrimer conjugates overcome drug resistance in breast cancer.

机构信息

Institute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, PR China.

Department of Pharmacy, the Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, 310009, PR China.

出版信息

Nanomedicine (Lond). 2016 Nov;11(22):2917-2934. doi: 10.2217/nnm-2016-0252. Epub 2016 Oct 26.

DOI:10.2217/nnm-2016-0252
PMID:27780403
Abstract

AIM

To design pluronic F68 (PF68)-conjugated polyamidoamine (PAMAM) dendrimer conjugates for doxorubicin (DOX) delivery for overcoming multidrug resistance, and clarify the reversal mechanism.

MATERIALS & METHODS: A series of PAMAM-PF68 conjugates were designed. The antitumor activity of the DOX-loaded conjugates was evaluated against MCF-7/ADR cells, tumor spheroids and tumors. Several bioinformatics were detected to characterize the reversal mechanism.

RESULTS

Increased antitumor activity of the DOX-loaded conjugates was achieved in vitro and in vivo. The complexes induced more DOX accumulation via caveolae-mediated endocytosis. After escaping from the endosome/lysosome, the nuclear trafficking of DOX was achieved. Apoptosis was significantly increased by regulating mitochondrial function and gene expression.

CONCLUSION

With optimized PF68 modification, PAMAM-PF68 conjugates can significantly overcome multidrug resistance in vitro and in vivo.

摘要

目的

设计阿霉素(DOX)传递用的泊洛沙姆 F68(PF68)-接枝聚酰胺-胺(PAMAM)树枝状大分子缀合物,以克服多药耐药性,并阐明逆转机制。

材料与方法

设计了一系列 PAMAM-PF68 缀合物。用载 DOX 的缀合物对 MCF-7/ADR 细胞、肿瘤球体和肿瘤进行抗肿瘤活性评估。通过几种生物信息学检测来表征逆转机制。

结果

在体外和体内均实现了载 DOX 缀合物的抗肿瘤活性增加。这些复合物通过穴样内陷介导的内吞作用诱导更多 DOX 蓄积。从内涵体/溶酶体逃逸后,实现了 DOX 的核转运。通过调节线粒体功能和基因表达,显著增加了细胞凋亡。

结论

通过优化的 PF68 修饰,PAMAM-PF68 缀合物可以显著克服体外和体内的多药耐药性。

相似文献

1
Pluronic-attached polyamidoamine dendrimer conjugates overcome drug resistance in breast cancer.接枝有普朗尼克的聚酰胺-胺树枝状大分子缀合物克服乳腺癌的耐药性。
Nanomedicine (Lond). 2016 Nov;11(22):2917-2934. doi: 10.2217/nnm-2016-0252. Epub 2016 Oct 26.
2
Chemosensitization of doxorubicin in multidrug-resistant cells by unimolecular micelles via increased cellular accumulation and apoptosis.单分子胶束通过增加细胞摄取和诱导凋亡实现对多药耐药细胞中阿霉素的化学增敏作用。
J Pharm Pharmacol. 2016 Mar;68(3):333-41. doi: 10.1111/jphp.12528. Epub 2016 Feb 19.
3
Preparation and in vitro characterization of pluronic-attached polyamidoamine dendrimers for drug delivery.用于药物递送的普朗尼克连接聚酰胺-胺树枝状大分子的制备及体外表征
Drug Dev Ind Pharm. 2015 May;41(5):812-8. doi: 10.3109/03639045.2014.908899. Epub 2014 Apr 18.
4
Co-delivery of cisplatin and doxorubicin by covalently conjugating with polyamidoamine dendrimer for enhanced synergistic cancer therapy.通过与聚酰胺-胺树枝状聚合物共价结合来共递送顺铂和阿霉素,以增强协同癌症治疗。
Acta Biomater. 2019 Jan 15;84:367-377. doi: 10.1016/j.actbio.2018.12.007. Epub 2018 Dec 5.
5
Polyamidoamine dendrimers-based nanomedicine for combination therapy with siRNA and chemotherapeutics to overcome multidrug resistance.基于聚酰胺-胺树枝状高分子的纳米医学用于联合治疗 siRNA 和化疗药物以克服多药耐药性。
Eur J Pharm Biopharm. 2019 Mar;136:18-28. doi: 10.1016/j.ejpb.2019.01.006. Epub 2019 Jan 8.
6
Effects of the surface charge of polyamidoamine dendrimers on cellular exocytosis and the exocytosis mechanism in multidrug-resistant breast cancer cells.聚酰胺-胺树枝状聚合物表面电荷对多药耐药乳腺癌细胞胞吐作用及胞吐机制的影响。
J Nanobiotechnology. 2021 May 12;19(1):135. doi: 10.1186/s12951-021-00881-w.
7
The interaction of dendrimer-doxorubicin conjugates with a model pulmonary epithelium and their cosolvent-free, pseudo-solution formulations in pressurized metered-dose inhalers.树枝状聚合物-阿霉素缀合物与模型肺上皮细胞的相互作用及其在压力定量吸入器中无共溶剂、假溶液制剂。
Eur J Pharm Sci. 2017 Nov 15;109:86-95. doi: 10.1016/j.ejps.2017.07.030. Epub 2017 Jul 31.
8
In vitro studies of phospholipid-modified PAMAM-siMDR1 complexes for the reversal of multidrug resistance in human breast cancer cells.磷脂修饰的聚酰胺-胺树枝状大分子-沉默多药耐药基因1复合物逆转人乳腺癌细胞多药耐药性的体外研究
Int J Pharm. 2017 Sep 15;530(1-2):291-299. doi: 10.1016/j.ijpharm.2017.06.026. Epub 2017 Jun 12.
9
Acid-Sensitive Peptide-Conjugated Doxorubicin Mediates the Lysosomal Pathway of Apoptosis and Reverses Drug Resistance in Breast Cancer.酸敏肽偶联阿霉素介导乳腺癌细胞凋亡的溶酶体途径并逆转耐药性
Mol Pharm. 2015 Jul 6;12(7):2217-28. doi: 10.1021/mp500386y. Epub 2015 Jun 2.
10
Redox and pH dual responsive poly(amidoamine) dendrimer-poly(ethylene glycol) conjugates for intracellular delivery of doxorubicin.用于阿霉素细胞内递送的氧化还原和pH双重响应性聚(酰胺胺)树枝状大分子-聚(乙二醇)共轭物
Acta Biomater. 2016 May;36:241-53. doi: 10.1016/j.actbio.2016.03.027. Epub 2016 Mar 16.

引用本文的文献

1
Multifaced Anticancer Potential of Doxorubicin: Spotlight on Breast Cancer.多柔比星的多面抗癌潜力:聚焦乳腺癌
Dis Res. 2025 Mar;5(1):19-36. doi: 10.54457/dr.202402015. Epub 2025 Jan 17.
2
Poloxamer-based drug delivery systems: Frontiers for treatment of solid tumors.基于泊洛沙姆的药物递送系统:实体肿瘤治疗的前沿领域。
Mater Today Bio. 2025 Apr 2;32:101727. doi: 10.1016/j.mtbio.2025.101727. eCollection 2025 Jun.
3
Exploring the Potential of Mitochondria-Targeted Drug Delivery for Enhanced Breast Cancer Therapy.探索线粒体靶向药物递送在增强乳腺癌治疗中的潜力。
Int J Breast Cancer. 2025 Mar 3;2025:3013009. doi: 10.1155/ijbc/3013009. eCollection 2025.
4
A nano drug delivery system loading drugs and chlorin e6 separately to achieve photodynamic-chemo combination therapy.一种分别负载药物和二氢卟吩e6以实现光动力-化学联合治疗的纳米药物递送系统。
Nanomedicine (Lond). 2025 Mar;20(6):559-570. doi: 10.1080/17435889.2025.2460960. Epub 2025 Feb 4.
5
Homologous-adhering/targeting cell membrane- and cell-mediated delivery systems: a cancer-catch-cancer strategy in cancer therapy.同源黏附/靶向细胞膜和细胞介导的递送系统:癌症治疗中的一种“癌捕癌”策略
Regen Biomater. 2024 Nov 21;12:rbae135. doi: 10.1093/rb/rbae135. eCollection 2025.
6
Recent advances in access to overcome cancer drug resistance by nanocarrier drug delivery system.纳米载体药物递送系统在克服癌症耐药性方面的最新进展。
Cancer Drug Resist. 2023 Jun 20;6(2):390-415. doi: 10.20517/cdr.2023.16. eCollection 2023.
7
Organic Nanodelivery Systems as a New Platform in the Management of Breast Cancer: A Comprehensive Review from Preclinical to Clinical Studies.有机纳米递送系统作为乳腺癌治疗新平台:从临床前研究到临床研究的全面综述
J Clin Med. 2023 Apr 2;12(7):2648. doi: 10.3390/jcm12072648.
8
Construction of Selenium Nanoparticle-Loaded Mesoporous Silica Nanoparticles with Potential Antioxidant and Antitumor Activities as a Selenium Supplement.负载硒纳米颗粒的介孔二氧化硅纳米颗粒的构建及其作为硒补充剂的潜在抗氧化和抗肿瘤活性
ACS Omega. 2022 Dec 1;7(49):44851-44860. doi: 10.1021/acsomega.2c04975. eCollection 2022 Dec 13.
9
Emerging indocyanine green-integrated nanocarriers for multimodal cancer therapy: a review.用于多模态癌症治疗的新型吲哚菁绿集成纳米载体:综述
Nanoscale Adv. 2021 Apr 15;3(12):3332-3352. doi: 10.1039/d1na00059d. eCollection 2021 Jun 15.
10
Recent advances in anti-multidrug resistance for nano-drug delivery system.纳米药物递送系统抗多药耐药性的最新进展。
Drug Deliv. 2022 Dec;29(1):1684-1697. doi: 10.1080/10717544.2022.2079771.